Tag Archives: CERN

Top Medical Stocks To Watch For 2019

&l;p&g;At first blush, you might think I&s;m a little late to the game with my annual &q;New Year&s;s Resolution&q; post. But my delay was actually a stroke of strategic genius. By waiting a few days to publish,&a;nbsp; I was allowing ample time for all of your &l;em&g;original&l;/em&g; goals for 2018 to fail miserably. And look at you now: It&s;s only January 5th, and you&s;re already back on gluten. You&s;ve given Jim a second chance. And you told the guy at the gym that you needed a full refund because you tore a muscle that, according to the latest medical research, does not actually exist.

&l;img class=&q;dam-image getty size-large wp-image-900179380&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/900179380/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; NEW YORK, NY – JANUARY 1: Fireworks explode in Times Square on New Year&s;s Eve on January 1, 2018 in New York City. (Photo by Stephanie Keith/Getty Images)

But you can still salvage 2018. You can still leave the year a better person than the one who entered. Now, I can&s;t whip you into shape, or get you to put down the pizza, or convince you that Jim is the worst (and he is), but I can make you a better tax professional. All you need to do are these five things:

Top Medical Stocks To Watch For 2019: Golden Ocean Group Limited(GOGL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D
  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Ethan Ryder]

    Jane Street Group LLC raised its holdings in shares of Golden Ocean Group Ltd (NASDAQ:GOGL) by 99.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 224,567 shares of the shipping company’s stock after purchasing an additional 111,971 shares during the period. Jane Street Group LLC owned approximately 0.16% of Golden Ocean Group worth $1,785,000 at the end of the most recent quarter.

Top Medical Stocks To Watch For 2019: Cerner Corporation(CERN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Rockefeller Capital Management L.P. acquired a new position in shares of Cerner (NASDAQ:CERN) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,402,230 shares of the company’s stock, valued at approximately $81,329,000. Cerner comprises 1.3% of Rockefeller Capital Management L.P.’s portfolio, making the stock its 22nd largest holding.

  • [By Jon C. Ogg]

    Cerner Corp. (NASDAQ: CERN) was raised to Buy from Neutral at Citigroup.

    Exxon Mobil Corp. (NYSE: XOM) was raised to Market Perform from Underperform at Raymond James.

  • [By Joseph Griffin]

    Quadrature Capital Ltd acquired a new stake in Cerner Co. (NASDAQ:CERN) in the first quarter, according to its most recent filing with the SEC. The fund acquired 4,557 shares of the company’s stock, valued at approximately $264,000.

  • [By Ethan Ryder]

    Cerner (NASDAQ:CERN) had its price objective decreased by SunTrust Banks to $58.00 in a research report sent to investors on Friday, The Fly reports. SunTrust Banks also issued estimates for Cerner’s Q1 2018 earnings at $0.55 EPS, Q2 2018 earnings at $0.60 EPS, Q3 2018 earnings at $0.65 EPS and Q4 2018 earnings at $0.64 EPS.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Cerner (CERN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Watch For 2019: Athersys, Inc.(ATHX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Athersys, Inc. (NASDAQ:ATHX) dropped 10.8% during mid-day trading on Tuesday after an insider sold shares in the company. The stock traded as low as $2.01 and last traded at $2.06. Approximately 2,886,300 shares were traded during mid-day trading, an increase of 278% from the average daily volume of 763,566 shares. The stock had previously closed at $2.31.

  • [By Ethan Ryder]

    Media stories about Athersys (NASDAQ:ATHX) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Athersys earned a news sentiment score of 0.20 on Accern’s scale. Accern also assigned news stories about the biopharmaceutical company an impact score of 44.8155037155159 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top Medical Stocks To Watch For 2019: Autohome Inc.(ATHM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

    Get Autohome alerts:

    Dow Jones Falls Before Trump’s Iran Decision; These 2 IBD 50 Stocks Jump (investors.com) Autohome Quarterly Earnings Beat Estimates, Guides Higher (finance.yahoo.com) Autohome (ATHM) Posts Earnings Results, Beats Expectations By $0.11 EPS (americanbankingnews.com) Earnings Reaction History: Autohome Inc., 44.4% Follow-Through Indicator, 4.6% Sensitive (nasdaq.com) BRIEF-Autohome Reports Qtrly Earnings Per Share Of RMB 4.05 (reuters.com)

    Several analysts have recently commented on the stock. ValuEngine raised shares of Autohome from a “hold” rating to a “buy” rating in a research report on Wednesday, April 11th. Zacks Investment Research raised shares of Autohome from a “hold” rating to a “buy” rating and set a $99.00 price objective for the company in a research report on Monday, March 12th. One analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $73.97.

  • [By Max Byerly]

    Autohome (NYSE: ATHM) and Pegasystems (NASDAQ:PEGA) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

  • [By Leo Sun]

    Tencent’s and JD’s investments inBitauto, which date back over three years, allow the two companies to expand their ecosystems into the online automotive market. By tethering itself to Tencent’s WeChat and JD’s online marketplace, Bitauto widens its moat against Autohome (NYSE:ATHM), its primary rival.

Top Medical Stocks To Watch For 2019: Inphi Corporation(IPHI)

Advisors’ Opinion:

  • [By Max Byerly]

    News coverage about Inphi (NYSE:IPHI) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Inphi earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news coverage about the semiconductor company an impact score of 46.0564611984507 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By ]

    There are some companies that have weak fundamentals and are regularly incurring losses but that are valued strongly by the market purely based on one metric: revenue growth. Inphi Corporation (NYSE:IPHI) is the perfect example of such a company that has enjoyed a very high valuation despite being a loss-making unit for a large period within the past five years. The companys revenue growth was phenomenal and the profits were expected soon. In fact, the company did end up with a good profit in 2016 when the EV/Sales multiple shot up above 7.

  • [By Timothy Green]

    Shares of Inphi Corp. (NYSE:IPHI) dropped on Wednesday following a mixed first-quarter report and a subsequent analyst downgrade. The company’s revenue declined sharply and came in just short of analyst expectations. The stock was down about 9.5% at 2:45 p.m. EDT.

  • [By Paul Ausick]

    Inphi Corp. (NYSE: IPHI) fell about 8.6% Friday to post a new 52-week low of $32.36 after closing at $35.40 on Thursday. The 52-week high is $51.78. Volume of about 3 million was roughly five times the daily average of around 680,000 shares traded. The company had no specific news.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Inphi (IPHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ezra Schwarzbaum]

    Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

    Lumentum Holdings Inc (NASDAQ: LITE)
    Ciena Corporation (NYSE: CIEN)
    Coherent, Inc. (NASDAQ: COHR)
    II-VI, Inc. (NASDAQ: IIVI)
    Inphi Corporation (NYSE: IPHI)
    Skyworks Solutions Inc (NASDAQ: SWKS)
    Integrated Device Technology Inc (NASDAQ: IDTI)
    Qorvo Inc (NASDAQ: QRVO)
    Xilinx, Inc. (NASDAQ: XLNX)
    Broadcom Inc (NASDAQ: AVGO)

    Related Links:

Top 10 Warren Buffett Stocks To Buy Right Now

It is the painful truth Wall Street doesn’t want you to know. All that time you spent researching mutual funds and comparing star ratings in hopes of the finding a Warren Buffett was a waste. You would have been better off watching cat videos and creating memes to cyber shame United Airlines. You could have beaten 90% of mutual fund managers the past 15 years by investing in plain-vanilla index funds like SPDR S&P 500 ETF, Vanguard 500 Index Fund or Vanguard Total Stock Market Index Fund.

The SPIVA® U.S. Scorecard, issued by S&P Dow Jones Indices today, reveals the vast majority of mutual funds across the board fail to surpass their benchmarks in both the short and long term. Two-thirds of large-cap funds, 89% of mid-cap funds and 86% of small-cap funds lagged their indexes last year.

FILE: Fidelity Investments is the nation’s largest mutual fund company. (AP Photo/Lisa Poole, File)

Top 10 Warren Buffett Stocks To Buy Right Now: AVG Technolo gies N.V.(AVG)

Advisors’ Opinion:

  • [By Igor Novgorodtsev]

    InterActiveCorp (IACI) bought Ask.com for $1.85 billion in 2005. The new Perion will be worth only about 40% of that. After the merger, Perion will leapfrog its much larger rivals: Babylon and AVG (AVG). Finally, Perion should be able to increase its operating margins as it can spread its SG&A costs over a much larger base (Conduit EBITDA margin is 32% vs. Perion’s 23%). Perion will keep its senior management team intact: Josef Mandelbaum will remain its CEO and Yacov Kaufman its CFO. Perion has successfully orchestrated a roll-up acquisitions of privately-held Sweetpacks and Smilebox, so I have high confidence that they know how to integrate a new business.

Top 10 Warren Buffett Stocks To Buy Right Now: Marathon Oil Corporation(MRO)

Advisors’ Opinion:

  • [By Paul Ausick]

    Marathon Oil Corp. (NYSE: MRO) dropped about 1% Thursday to post a new 52-week low of $11.50 after closing Wednesday at $11.61. The 52-week high is $19.28. Volume was about 30% lower than the daily average of about 13.7 million shares. The company had no specific news.

  • [By Paul Ausick]

    Marathon Oil Corp. (NYSE: MRO) dropped about 1.6% Friday to post a new 52-week low of $11.41 after closing Thursday at $11.59. The 52-week high is $19.28. Volume was about 30% lower than the daily average of about 13.7 million shares. The company had no specific news.

  • [By Ben Levisohn]

    Marathon Oil (MRO) tumbled to the bottom of the S&P 500 today after oil tumbled after data pointed to higher inventories of crude.

    Agence France-Presse/Getty Images

    Marathon Oildropped 8.7% to $14.87, while the S&P 500 fell 0.2% to 2,362.98, as Front Month Nymex Crude futures for April delivery slid 5.4% to $50.28., leading some to wonder if the price oil could drop below $50 a barrel.

    It wasn’t just Marathon that got clipped as the eight worst-performing stocks in the S&P 500 came from the energy sector, including Murphy Oil (MUR), which fell 6.7% to $25.87, Devon Energy (DVN), which slid 6.5% to $40.72, and Chesapeake Energy (CHK), which stumbled 6.1% to $4.94. No surprise, then, that the Energy Select Sector SPDR ETF (XLE) slumped 2.6% to $69.65.

    The oil rout began after the U.S. Energy Information Administration reported that U.S. oil inventories rose by 8.2 million barrels to reach $518.4 million, a record level.

    Marathon Oil’s market capitalization fell to $12.6 billion today from $13.8 billion yesterday. It reported a net loss of $2.1 billion on sales of $4.1 billion in 2016.

  • [By Paul Ausick]

    Marathon Oil Corp. (NYSE: MRO) dropped about 1.1% Monday to post a new 52-week low of $11.40 after closing Friday at $11.53. The 52-week high is $19.28. Volume was about 40% lower than the daily average of about 13.7 million shares. The company had no specific news.

  • [By WWW.THESTREET.COM]

    Cramer said he tried to buck this trend by investing in EOG Resources (EOG) and Marathon Oil (MRO) but was wrong on both counts. In the case of EOG, even having the best properties wasn’t enough to ward off the collapse in oil prices. Meanwhile, Marathon’s decision to spin off its refining business left it with no cushion to stem its losses.

  • [By Shanthi Rexaline]

    The bulking up strategy did not work well for the company over the years, as it saw its market share dwindle and profitability erode. In 1982, in a diversification bid, the company picked up Marathon Oil Corporation (NYSE: MRO) and renamed itself as USX.

Top 10 Warren Buffett Stocks To Buy Right Now: Monsanto Company(MON)

Advisors’ Opinion:

  • [By Chris Lange]

    Monsanto Co.’s (NYSE: MON) latest quarterly earnings report is expected on Wednesday. The consensus analyst estimates are $1.77 in earnings per share (EPS) and $4.17 billion in revenue. Shares closed trading most recently at $117.02, in a 52-week range of $97.35 to $118.15. The consensus price target is $122.66.

  • [By Maxx Chatsko]

    BeforeBayer(NASDAQOTH: BAYRY)arrived onto the scene, I viewedMonsanto(NYSE: MON)as an intriguing growth stock. It has a rich history of delivering value to shareholders and continues to hold a dominant technological edge over key competitors in crop protection products, seeds, and traits. While little has changed its promising pipeline and portfolio, the pending acquisition throws a wrench in anyone’s plans to start or add to a position. Uncertainty stemming from the merger provides several terrible reasons to buy Monsanto at this time.

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

Top 10 Warren Buffett Stocks To Buy Right Now: Harmony Gold Mining Company Limited(HMY)

Advisors’ Opinion:

  • [By Javier Hasse]

    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 2.2 percent on Friday, even though gold prices dropped. However, the stock lost 3.7 percent in after-hours trading, in what also seemed like a correction of the surge seen during the day.

  • [By Lisa Levin] Gainers Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter. Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba. Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision. Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results. Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter. AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday. Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share. Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday. Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday. Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin]

    On Wednesday, basic materials shares surged by 0.6 percent. Top gainers in the sector included Harmony Gold Mining Co. (ADR) (NYSE: HMY) and Gold Fields Limited (ADR) (NYSE: GFI).

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 0.73 percent. Meanwhile, top losers in the sector included Silver Wheaton Corp. (USA) (NYSE: SLW), down 5 percent, and Harmony Gold Mining Co. (ADR) (NYSE: HMY), down 5 percent.

  • [By Alex McGuire]

    This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…

    Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30) DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24% Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98% Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56% Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73% Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89% Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27% Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25% Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16% Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75% Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%

    Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.

  • [By Lisa Levin]

    In trading on Friday, basic materials shares tumbled by 1.20 percent. Meanwhile, top losers in the sector included McEwen Mining Inc (NYSE: MUX), down 6 percent, and Harmony Gold Mining Co. (ADR) (NYSE: HMY), down 6 percent.

Top 10 Warren Buffett Stocks To Buy Right Now: Investment Technology Group, Inc.(ITG)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Investment Technology Group Inc. (NYSE: ITG) was downgraded to Market Perform from outperform by KeefeBruyette & Woods.

    Liquidity Services Inc. (NASDAQ: LQDT) was raised to Buy from Underperform, and the price target was raised up to $45 from $28.50, at Merrill Lynch.

Top 10 Warren Buffett Stocks To Buy Right Now: American Airlines Group, Inc.(AAL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Oglenski assigned a $105 price target to United Continental, a $33 target to JetBlue, and a $122 target to Alaska Air. And even his equal weights, like America Airlines (AAL) and Southwest Airlines (LUV) have “material upside,” Oglenski says. He expects American to hit $62, and Southwest to hit $65.

  • [By Adam Levine-Weinberg]

    A few years ago, Delta Air Lines (NYSE:DAL) introduced a new class of cheaper “basic economy” fares to help it compete with ultra-low cost carriers on certain routes. Last year, American Airlines (NASDAQ:AAL) and United Continental (NYSE:UAL) confirmed that they would introduce their own basic economy fares to stay competitive.

  • [By Teresa Rivas]

    American Airlines (AAL) soared to the top of the S&P 500 today.

    Getty Images

    The shares climbed $1.61, or 3.8%, to $43.93, compared to the S&P 500, which fell 3.38 points, or 0.14%, to 2353.78.

    Investors cheered American Airlines increased first-quarter unit revenue and margin guidance.

    The airline said it expects first-quarter total revenue per available seat mile to be up between 2% and 4% year over year, compared to previous guidance for a 1.5% to 3.5% increase. It expects adjusted pre-tax margins to be between 4% and 6%, compared to previous guidance of 3% to 5%.

    For the month of March, it said that revenue passenger miles and available seat miles were down.

    Fellow airline United Continental(UAL) also released March metrics today, although it down on the backlash to a video showing apassenger being dragged off a plane.

    Whole Foods Market(WFM)was the best performer in the S&P 500 yesterday.

  • [By Ben Levisohn]

    Shares of American Airlines (AAL) are soaring today after Stifel named the stock to Stifel Select List. But it’s the reason for Stifel’s optimism, more than the addition itself, that is eye catching.

    Agence France-Presse/Getty Images

    See, American Airlines has been under pressure this year–its dropped 11% so far in 2017–on fears that increased capacity would reduce its profitability. The same fears have also dented United Continental Holdings (UAL) and Delta Air Lines (DAL).

    Stifel’s Joseph DeNardi and Matthew Rachal, however, argue that the increased capacity at American Airlines doesn’t matter thanks to a revenue stream that the market has ignored: The revenue from its frequent flier program. They explain why:

    The consensus price target on American, excluding us at $95, of $54 reflects a fundamental misunderstanding of the source of American’s earnings, in our view. Within American is an operating segment that accounts for ~50% of EBIT, is growing revenue at ~10% per year with a 65%-70% operating margin with very low capital requirements and very high barriers to entry. We know it exists. American Airlines knows it exists. But the vast majority of the investment community does not or, at this point, is skeptical that it does. We attribute this to a lack of information supplied by the companies for investors to properly assess the size and profitability of airline loyalty programs. We are confident that this will change in the near-to-mid term as disclosures begin to improve over the next several months followed by the reporting of the business as its own operating segment in 12-18 months.

    How big a deal could this be? DeNardi and Rachal argue that the AAdvantage program could generate about $2.7 billion in 2018, greater than the $2.5 billion in pre-tax earnings implied by the consensus estimate of $3.50 a share in 2018. They call it “an earnings stream immune from incremental capac

Top 10 Warren Buffett Stocks To Buy Right Now: Sanderson Farms Inc.(SAFM)

Advisors’ Opinion:

  • [By Peter Graham]

    Midcap poultry processing stock Sanderson Farms, Inc (NASDAQ: SAFM) reported fiscal Q3 earnings before the market opened on Thursday. Net sales were $931.9 million versus $728.0 million and net incomewas $115.8 million versusnet income of $54.7 million for the third quarter of fiscal 2016. The earnings release noted that compared with the third fiscal quarter of 2016, market prices for chickens sold to retail grocery store customers remained relatively flat at levels that reflect a good supply and demand balance. Compared with the third fiscal quarter of 2016, jumbo boneless breast meat prices were higher by approximately 24.8%, the average market price for bulk leg quarters increased approximately 15.9%, and jumbo wing prices were higher by 40.2%. The Company’s average feed cost per pound of poultry products processed decreased 0.32 cents per pound, or 1.3%, compared with the third quarter of fiscal 2016.

  • [By Peter Graham]

    A long term performance chart shows Pilgrim’s Pride Corporation having performed better over the longer term than large cap Tyson Foods, Inc (NYSE: TSN) andsmall cap Sanderson Farms, Inc (NASDAQ: SAFM):

  • [By Peter Graham]

    The Q1 2017 earnings report for small cap poultry processing stock Sanderson Farms, Inc (NASDAQ: SAFM) is scheduled for before the market opens on Thursday (February 23rd) as shares still have elevated short interest of 33.50% according to Highshortinterest.comdue in part to fears over bird flu.

Top 10 Warren Buffett Stocks To Buy Right Now: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By David Zeiler]

    Bill Patalon’s initial stock pick was Galapagos NV (Nasdaq ADR: GLPG), a Belgian biotech company.

    Patalon was attracted to Galapagos’ strategy to target “orphan diseases,” afflictions that strike rarely and so often go ignored by the Big Pharma companies. He also liked that Galapagos had more than 50 drug discovery programs underway, and that it already had licensing agreements with several bigger players in the industry.

  • [By Stephen Mack]

    Galapagos NV (Nasdaq: GLPG) is our big winner so far, gaining 578.8% since Money Morning Executive Editor Bill Patalon shared his recommendation with Money Morning readers in April 2012. The S&P 500 has gained 75.4% in the same time. Bill has renewed his recommendation for the Belgian biotech several times over the years, saying in 2016 that it has “an established history of piling on gains.” With an average gain of 110% a year, it’s hard to argue with that.

Top 10 Warren Buffett Stocks To Buy Right Now: Safe Bulkers Inc(SB)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Meanwhile, Safe Bulkers, Inc. (NYSE: SB) rose $0.73 throughout the 2016, Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) fell $1.69 and Navios Maritime Partners L.P. (NYSE: NMM) dropped $0.93.

  • [By Ben Levisohn]

    StarBulk Carriers (SBLK) and Safe Bulkers (SB) have more than tripled during the past 12 months, while Golden Ocean Group (GOGL) has more than doubled. So it must be time for an upgrade right?

Top 10 Warren Buffett Stocks To Buy Right Now: Cerner Corporation(CERN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Cerner (CERN) tumbled to the bottom of the S&P 500 today after meetings earnings forecasts but offering below-consensus guidance.

    Agence France-Presse/Getty Images

    Cerner dropped 4.4% to $51.50 today, while the S&P 500 rose 0.4% to 2,316.10.

    SunTrust Robinson Humphrey’s Sandy Draper and team contend that “most of the bad news is already priced in.” They explain:

    Although we expect this news to weigh on the stock…we think the market has remained cautious on CERN shares heading into the 4Q16 print given the uneven execution throughout 2016 and the post-election regulatory uncertainty that has broadly weighed on the HCIT space as a whole. We observe that CERN shares closed about 3% below the level they traded at this time last year, while the S&P was up over 21% in that time. The muted 12-month performance in the stock suggests the market rightly anticipated unattractive year-end results and 2017 guidance, which suggests to us that downside to CERN shares should be limited.

    Cerner’s market capitalization fell to $17.5 billion today from $18.3 billion yesterday.

    Barron’s Vito Racanelli recommended shares of Cerner on March 16, 2016, when the stock traded at $51.46.

  • [By Ben Levisohn]

    Cerner (CERN) soared to the top of the S&P 500 today after thehealth care information technology company reported better-than-expected earnings and revenue.

    Getty Images

    Cernergained 7.8% to $64.75 at 5:03 p.m. today, while the S&P 500 declined 0.2% to 2,384.20.

    Canaccord Genuity’s Richard Close and Brian Hoffman contend Cerner may be “rediscovered its mojo.” They explain:

    We reiterate our BUY rating and raise our PT to $66 (was $59) as the company finally
    appears to have provided quarterly and annual targets that it can meet. Possibly more important, analyst expectations sit near the mid-point of guidance, portending upside potential. The outlook appears solid as the company (1) rebuilds a track record of delivering on expectations, (2) reaffirmed confidence in 2017 bookings growth, and (3) has a strengthened pipeline for ITWorks and revenue cycle. CERN may have rediscovered its mojo.

    Cerner’s market capitalization rose to $21.4 billion today from $19.8 billion yesterday.

investment shares

The common theme among cars dubbed “Tesla (NASDAQ:TSLA) Killers” is that they are long-range electric cars. I’ll look at a few cars dubbed Tesla killers and then look at what a real Tesla killer would need to be.

The Tesla “Killers”

The Chevy (NYSE:GM) Bolt is the first supposed Tesla killer to hit the market. The expectations set by GM were very high with confident and bold statements like:

GM’s balance sheet is in pretty strong shape, so we don’t need to take $1,000 of your money just to hold a spot

Source: Electrek

For GM, the Bolt stands to offer a head start in a new kind of market for electric cars. But for the rest of us, there’s a broader significance to this news. It’s not just that Chevy will likely be first. It’s that a car company as lumbering and gigantic as GM, with infrastructure and manufacturing capacity on an epic scale, has gotten there first – and is there now. Tesla is nimble, innovative, and fun to watch, as companie s go. But the Bolt is far more significant than any offering from Tesla ever could be. Why? Think of the old saw about how long it takes to turn an aircraft carrier around: It’s slow, and there’s not much to see at any given moment. But the thing about people who actually manage to turn one around is: They’ve got a freaking aircraft carrier.

investment shares: Charter Communications, Inc.(CHTR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of OBERNDORF WILLIAM E’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=OBERNDORF+WILLIAM+E

    These are the top 5 holdings of OBERNDORF WILLIAM EWorkiva Inc (WK) – 2,369,384 shares, 43.81% of the total portfolio. Shares added by 38.81%AppFolio Inc (APPF) – 839,797 shares, 26.98% of the total portfolio. Shares reduced by 39.22%Liberty Global PLC (LBTYK) – 289,812 shares, 12% of the total portfolio. Herbalife Ltd (HLF) – 145,000 shares, 9.96% of the total portfolio. Charter Communications Inc (CHTR) – 18,758 shares, 7.25% of the total portfolio.

  • [By Adam Levy]

    Image source: Getty Images.

    It was just a little more than a year ago when Comcast (NASDAQ:CMCSA) was the largest U.S. pay-TV provider. And it wasn’t even close. But after AT&T (NYSE:T) merged with DirecTV, it took over the top spot. Now, AT&T’s rival telecom company, Verizon (NYSE:VZ), is reportedly considering a megamerger of its own with Charter Communications (NASDAQ:CHTR). The move would put the combined company’s total video subscriber count very close to Comcast’s.

    The potential merger points to a big hole in Comcast’s service offerings — its lack of wireless service. If customers can save money by bundling their TV, internet, and wireless bills together with its competitors, Comcast stands to lose customers. But Comcast’s management and investors shouldn’t lose sleep over the possibility that its two biggest competitors offer wireless service.

  • [By Andrew Tonner]

    As one of the group of companies associated with telecom magnate John Malone — who regularly uses complex, tax-efficient corporate transactions to unlock value for shareholders — Liberty Broadband serves as a holding company that controls a diverse set of media assets. The most important of these is Liberty Broadband’s ownership of 25% of Charter Communications’ (NASDAQ:CHTR) total voting power, which effectively makes Liberty Broadband a tracking stock for Charter Communications shares.As such, Liberty Broadband shares have largely mirrored the impressive rally in Charter Communications stock over the past year. Particularly given Charter’s upcoming launch of its own wireless service network, Soros’ investment in Liberty Broadband remains an interesting option as the cable and telecom industries continue to evolve.

investment shares: Cray Inc(CRAY)

Advisors’ Opinion:

  • [By Giulio Prisco]

    Microsoft (NSDQ:MSFT), supercomputer maker Cray (NSDQ:CRAY), and the Swiss National Supercomputing Centre (CSCS), a world-class scientific computing center, announced the results of a deep learning collaboration that expands the horizons of running Artificial Intelligence (AI), Machine Learning (ML), and in particular Deep Learning (an especially promising branch of ML) applications, using Microsoft software and Cray supercomputers.

  • [By Peter Graham]

    The Q4 2016 earnings report for small capsupercomputer stock Cray Inc (NASDAQ: CRAY) is scheduled forafter the market closes onWednesday (February 8th). Back in 2012, Cray Inc was inour SmallCap Network Elite Opportunity (SCN EO) portfolioasa potentially goodlow risk longer-term play as shares were trading at the $12 level and eventually hit $40+ per share before coming back down to earth last year.

investment shares: Cerner Corporation(CERN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Cerner (CERN) soared to the top of the S&P 500 today after thehealth care information technology company reported better-than-expected earnings and revenue.

    Getty Images

    Cernergained 7.8% to $64.75 at 5:03 p.m. today, while the S&P 500 declined 0.2% to 2,384.20.

    Canaccord Genuity’s Richard Close and Brian Hoffman contend Cerner may be “rediscovered its mojo.” They explain:

    We reiterate our BUY rating and raise our PT to $66 (was $59) as the company finally
    appears to have provided quarterly and annual targets that it can meet. Possibly more important, analyst expectations sit near the mid-point of guidance, portending upside potential. The outlook appears solid as the company (1) rebuilds a track record of delivering on expectations, (2) reaffirmed confidence in 2017 bookings growth, and (3) has a strengthened pipeline for ITWorks and revenue cycle. CERN may have rediscovered its mojo.

    Cerner’s market capitalization rose to $21.4 billion today from $19.8 billion yesterday.

  • [By Ben Levisohn]

    Cerner (CERN) tumbled to the bottom of the S&P 500 today after meetings earnings forecasts but offering below-consensus guidance.

    Agence France-Presse/Getty Images

    Cerner dropped 4.4% to $51.50 today, while the S&P 500 rose 0.4% to 2,316.10.

    SunTrust Robinson Humphrey’s Sandy Draper and team contend that “most of the bad news is already priced in.” They explain:

    Although we expect this news to weigh on the stock…we think the market has remained cautious on CERN shares heading into the 4Q16 print given the uneven execution throughout 2016 and the post-election regulatory uncertainty that has broadly weighed on the HCIT space as a whole. We observe that CERN shares closed about 3% below the level they traded at this time last year, while the S&P was up over 21% in that time. The muted 12-month performance in the stock suggests the market rightly anticipated unattractive year-end results and 2017 guidance, which suggests to us that downside to CERN shares should be limited.

    Cerner’s market capitalization fell to $17.5 billion today from $18.3 billion yesterday.

    Barron’s Vito Racanelli recommended shares of Cerner on March 16, 2016, when the stock traded at $51.46.

investment shares: Clean Energy Fuels Corp.(CLNE)

Advisors’ Opinion:

  • [By Michael Vodicka]

    Clean Energy Fuels Corp. (CLNE) designs, builds and operates natural gas filling stations in the United States. The company supplies compressed natural gas (CNG) and liquefied natural gas (LNG), serving a fleet of 650 customers, more than 32,000 natural-gas vehicles while owning or supplying more than 350 filling stations in 32 states.

  • [By Lisa Levin]

    In trading on Wednesday, energy shares fell by 1.72 percent. Meanwhile, top losers in the sector included Clean Energy Fuels Corp (NASDAQ: CLNE), down 5 percent, and Frontline Ltd. (NYSE: FRO), down 7 percent.

  • [By Jason Hall]

    Natural gas for transportation leader Clean Energy Fuels Corp (NASDAQ:CLNE) has steadily grown and improved the quality of its business and business results over the past several years. Today’s Clean Energy Fuels is leaner, has a stronger balance sheet, and is in a solid position as a market leader in a growth industry.

investment shares: Carrizo Oil & Gas, Inc.(CRZO)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Medifast Inc. (NYSE: MED), Medley Capital Corp. (NYSE: MCC), Occidental Petroleum Corp. (NYSE: OXY) and Sothebys (NYSE: BID).

  • [By Paul Ausick]

    Carrizo Oil & Gas Inc. (NASDAQ: CRZO) is rated a Buy with a lowered price target of $48. The EPS estimate for 2017 has been lowered from $1.65 to $1.41, and the 2018 estimate was raised from $3.90 to $4.02. Shares closed Friday at $31.18, in a 52-week range of $24.18 to $43.96, and the consensus 12-month estimate is $46.52.

  • [By Matthew DiLallo]

    In addition, it sold several non-core acreage packages. Its largest transaction was the sale of some non-core Eagle Ford shale assets to Carrizo Oil & Gas (NASDAQ:CRZO) for $181 million. These deals boosted the company’s cash position up to $525 million, which along with another $300 million in available credit, provided Sanchez with a war chest to use in pursuit of an accretive acquisition.

investment shares: Paychex Inc.(PAYX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Paychex, Inc. (NASDAQ: PAYX) reported better-than-expected earnings for its third quarter on Wednesday.

    Paychex posted Q3 earnings of $0.56 per share on revenue of $795.8 million. However, analysts were expecting earnings of $0.54 per share on revenue of $799.0 million.

  • [By Monica Gerson]

     

    Darden Restaurants, Inc. (NYSE: DRI) is estimated to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion. ConAgra Foods Inc (NYSE: CAG) is expected to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion. Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.49 per share on revenue of $751.52 million. Micron Technology, Inc. (NASDAQ: MU) is expected to post a quarterly loss at $0.09 per share on revenue of $2.95 billion. McCormick & Company, Incorporated (NYSE: MKC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.06 billion. Constellation Brands, Inc. (NYSE: STZ) is expected to report its quarterly earnings at $1.51 per share. Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) is estimated to report its quarterly earnings at $0.18 per share on revenue of $356.41 million. Franklin Covey Co. (NYSE: FC) is expected to post its quarterly earnings at $0.08 per share on revenue of $49.89 million. Lindsay Corporation (NYSE: LNN) is projected to report its quarterly earnings at $0.99 per share on revenue of $148.43 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

  • [By Monica Gerson]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Paychex, Inc. (NASDAQ: PAYX) is estimated to report its quarterly earnings at $0.49 per share on revenue of $751.52 million. Paychex shares rose 1.10 percent to close at $56.14 on Wednesday. Wall Street expects Micron Technology, Inc. (NASDAQ: MU) to post a quarterly loss at $0.09 per share on revenue of $2.95 billion. Micron shares rose 0.76 percent to $13.29 in after-hours trading. Pier 1 Imports Inc (NYSE: PIR) reported a wider-than-expected loss for its first quarter and issued a weak outlook. Pier 1 Imports shares dropped 6.07 percent to $5.11 in the after-hours trading session. Analysts are expecting McCormick & Company, Incorporated (NYSE: MKC) to have earned $0.74 per share on revenue of $1.06 billion in the latest quarter. McCormick shares fell 0.59 percent to $102.10 in after-hours trading.

    Posted-In: Stocks To WatchEarnings News Guidance Pre-Market Outlook Markets Trading Ideas

Best Warren Buffett Stocks To Own For 2017

Warren Buffett recently told CNBC he didn’t have a good reason for not investing in Amazon stock. Here are a few good reasons why you should.
123RF

Shares of Amazon.com Inc (NASDAQ:AMZN)have racked up decent gains this year,and are up by over 13% in under three months. That’s more than what the stock eventually returned in 2016 after big intermittent swings on both sides. However, if you’re a long term investor, and are considering an investment in AMZN stock, that shouldn’t stop you. In spite of the stellar growth it has registered in recent years, Amazon has a lot of room for growth, and the stock is likely to deliver healthy long term returns. Amazon’s focus on growth may not go down too well with all types of investors though. For instance, if you’re a value investor like the legendary Warren Buffett, Amazon stock may not appeal to you all that much. But if you’re chasing influential companies that can deliver high growth rates, you should definitely take a look at Amazon (NASDAQ:AMZN).

Best Warren Buffett Stocks To Own For 2017: Cerner Corporation(CERN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Cerner (CERN) tumbled to the bottom of the S&P 500 today after meetings earnings forecasts but offering below-consensus guidance.

    Agence France-Presse/Getty Images

    Cerner dropped 4.4% to $51.50 today, while the S&P 500 rose 0.4% to 2,316.10.

    SunTrust Robinson Humphrey’s Sandy Draper and team contend that “most of the bad news is already priced in.” They explain:

    Although we expect this news to weigh on the stock…we think the market has remained cautious on CERN shares heading into the 4Q16 print given the uneven execution throughout 2016 and the post-election regulatory uncertainty that has broadly weighed on the HCIT space as a whole. We observe that CERN shares closed about 3% below the level they traded at this time last year, while the S&P was up over 21% in that time. The muted 12-month performance in the stock suggests the market rightly anticipated unattractive year-end results and 2017 guidance, which suggests to us that downside to CERN shares should be limited.

    Cerner’s market capitalization fell to $17.5 billion today from $18.3 billion yesterday.

    Barron’s Vito Racanelli recommended shares of Cerner on March 16, 2016, when the stock traded at $51.46.

Best Warren Buffett Stocks To Own For 2017: Cipher Pharmaceuticals Inc.(CPHR)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Cipher Pharmaceuticals (NASDAQ: CPHR) is said to have hired an investment bank to explore strategic alternatives, according to sources as reported by Reuters on Monday. The sources said a potential sale of the Canada-based company is being considered. Cipher declined comment on the report.

Best Warren Buffett Stocks To Own For 2017: Athene Holding Ltd. (ATH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Edwards Lifesciences Corp (NYSE: EW) announced plans to buy Valtech Cardio for $340 million in cash and stock. The company also announced a $1 billion buyback plan. Epizyme Inc (NASDAQ: EPZM) disclosed that it has received Fast Track designation for tazemetostat. Athene Holding Ltd. (NYSE: ATH) reported that it has priced its 23.8 million share IPO between $38 per share and $42 per share. Lannett Company, Inc. (NYSE: LCI) reported the approval for its Metaxalone Tablets USP, 800 mg.

Best Warren Buffett Stocks To Own For 2017: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Ben Levisohn]

    How good were UnitedHealth Group’s (UNH) earnings today? So good its stock has jumped the most in more than six years–and lifted competitors like Humana (HUM), Cigna (CI), Aetna (AET), and Anthem (ANTM) as well. Leerink’s Ana Gupte explains why the market is in love with UnitedHealth’s earnings:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Humana Inc. (NYSE: HUM) which jumped 2.4% to $217.76. The gain was following news that Trump had endorsed the House Republican health care plan. Also Humana is teaming up with Quartet to deliver integrated mental health care to New Orleans residents. The stocks 52-week range is $150.00 to $218.92. Volume was about 26% above the daily average of around 1.7 million shares.

Best Warren Buffett Stocks To Own For 2017: Chunghwa Telecom Co., Ltd.(CHT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, telecommunications services shares fell by 0.99 percent. Meanwhile, top losers in the sector included Chunghwa Telecom Co., Ltd (ADR) (NYSE: CHT), down 3 percent, and Shenandoah Telecommunications Company (NASDAQ: SHEN), down 4 percent.

Inovalon: Potential Takeover Target In 2017

Inovalon (NASDAQ: INOV) sells its cloud based health care data to health plans and pharmaceutical companies across the United States. The company has data on 139 million members (~42% of the U.S. population) and has data on nearly 12 billion medical events covering nearly 99% of U.S. counties. Inovalon is Samadhi Partners #1 M&A target for 2017.

Inovalon’s client base includes 76% of the top health plans by size and 87% of the top pharmaceutical/life science companies. Inovalon’s cloud database and analytics platform – mainly its MORE2 registry gets smarter the more users it acquires and offers deeper data analytics capabilities. This machine learning technology is how Google came to dominate search. Inovalon’s massive data sets makes it difficult for competitors to compete in the healthcare space. Moreover, Inovalon’s QSI-XL cloud based data analytics platform gets faster the more users it has. Inovalon has nearly 140 million users and its processing speeds are unmatched. Inovalon’s data diagnostics reaches more than 50% of all physicians in the U.S. and accounts for 1.2 billion clinical encounters per year.

Key growth drivers for Inovalon include value add volume upselling to existing client base because Inovalon’s processing speed gets faster with increased use. Key highlights for 2016 included sales pipeline quadrupling, additional $15 billion in TAM, increased product expansion and marketing investments. Moreover, Inovalon has expanded its Electronic Health Record (EHR) interconnections more than 200% yoy over the last several years. EHR enables highly efficient data exchange automation, reduces costs, and increases stickiness of the client base as evidenced by a 44% cost reduction of clinical data aggregation. Total addressable market for Inovalon’s EHR platform is approaching 60% of the U.S. clinical market.

What has created this opportunity?

Inovalon was founded in 1999 and its focus was to acquire as much data as possible for patients and healthcare providers. Inovalon IPO’d two years ago at $29 per share, more than double its current price. Inovalon has reduced revenue projections three quarters in a row and the stock is not popular on Wall Street. Furthermore, there is much uncertainty surrounding the future of Obamacare (aka Affordable Care Act or ACA) amid Trump’s rhetoric about repealing the healthcare legislation. Inovalon’s war chest of healthcare data will be valuable in determining the impacts of ACA legislation and how the resulting healthcare spend will impact the top and bottom lines for healthcare companies.

An acquisition for Inovalon seems more likely than not in the next 12 months because of the uncertainty surrounding Obamacare and the impact it could have on healthcare plans and pharmaceutical companies. Inovalon’s platform can provide more d ata insights on exactly how repealing or reforming the ACA could affect business for healthcare plans and companies.

Value to an Acquirer

Inovalon has sold off amidst reduced guidance and macro level uncertainty surrounding Obamacare. The stock has fallen nearly 60% since its IPO two years ago. Inovalon has a large cash reserves, low debt and its overcapitalized balance sheet is likely to be very attractive to an acquirer.

Inovalon’s closest public comp seems to be HealthStream (NASDAQ: HSTM) HealthStream trades at just over 3x sales. Inovalon’s projected revenue for 2016 is projected to be $430 – $450 million. Using a midrange of $440 million, Inovalon would be worth ~1.32 billion, or ~$21 per share. Inovalon has about $7 per share in net cash, so an acquirer could fund the premium with the net cash on the balance sheet. Shareholders would be getting at least a 65% premium over current prices assuming a $20 takeout price and an acquirer would be getting a goldmine of data at a bargain price. The most likely public acquirers are Athena (NASDAQ: ATHN) or Cerner (NASDAQ: CERN). They both have strong balance sheets and would likely fund the deal with a combination of cash and equity. There are also a few private equity firms that could buy Inovalon.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

SeekingAlphaAbout this article:ExpandAuthor payment: $35 + $0.01/page view. Authors of PRO articles receive a minimum guaranteed payment of $150-500. Become a contributor »Tagged: Investing Ideas, Long Ideas, HealthcareProblem with this article? Please tell us. Disagree with this article? Submit your own.